INS and type 2 diabetes mellitus: Metformin (Met) is currently the primary therapeutic agent used for insulin sensitization in individuals with PCOS, while glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly employed in the treatment of T2DM.